Oral Drug
- All
- News
- Videos
-
New Drug 95% Effective Against Sleeping Sickness In Adults: Lancet Study
A new, single-dose oral treatment for sleeping sickness is 95 per cent effective in adults and adolescents, regardless of disease stage, according to a study published in The Lancet Infectious Diseases.
-
Maharashtra Orders Sample Checks On All Syrups After WHO Alert: Report
The drug regulator of Maharashtra has ordered sample checks on all oral liquid solutions in the state, asking for reports on the levels of diethylene glycol and ethylene glycol, CNBC TV18 reported on Thursday.
-
Positive Results In Phase 3 Trial Of Covid Pill, Says Hetero Pharma Group
Drug firm Hetero on Saturday announced positive results of Phase III trials of Movfor (Molnupiravir), an investigational oral antiviral COVID-19 medicine.
-
Pfizer Covid Pill Europe's First Approved Oral Treatment Against Covid
The EU's drug watchdog approved Pfizer's coronavirus pill on Thursday, making it the first oral antiviral treatment for the disease to be authorised in Europe.
-
Game-Changing Made-In-India Anti-Covid Pills Could Be Cleared For Use In Days
Emergency Use Authorisation for the Merck drug Molnupiravir -- an oral antiviral medicine for the treatment of mild-to-moderate COVID-19 -- is likely "within days", Dr Ram Vishwakarma, Chairman of the Covid Strategy Group, CSIR, told NDTV today.
-
Hyderabad Firm Seeks Approval To Produce Generic Merck Covid Pill
The bulk drugs manufacturer Optimus Pharma is seeking domestic regulatory approval to produce a generic version of Merck & Co's oral COVID-19 treatment molnupiravir, the company's top executive told Reuters on Thursday.
-
Shilpa Medicare Gains On Receiving Nod For COVID-19 Adjunct Therapy Drug
2-Deoxy-2-Glucose Oral Powder is approved for the treatment of adjunct therapy in moderate to severe COVID-19 patients, Shilpa Medicare added.
-
Marksans Pharma Shares Gain On USFDA Approval For Pain Killer Drug
Marksans will manufacture the products at its US Food and Drug Administration (USFDA) approved solid oral dosage facility located at Goa.
-
Mankind Pharma Gets DRDO Nod To Manufacture, Sell Covid Drug 2-DG
Drug firm Mankind Pharma today said it has received licence from the Defence Research and Development Organisation (DRDO) to manufacture and market oral 2-deoxy-D-glucose (2-DG), used for the treatment of COVID-19.
-
Oral Drug For Black Fungus Ready for technology transfer: IIT Researchers
Researchers at Indian Institute of Technology, Hyderabad, have developed an oral solution to treat Black Fungus (Mucormycosis) and other fungi and are ready to transfer the technology to take it forward, the premier institute said.
-
First Batch Of Anti-COVID Drug 2-DG Released
The first batch of anti-COVID oral drug 2-DG, developed by the DRDO, was released on Monday by Defence Minister Rajnath Singh and Health Minister Harsh Vardhan.
-
10,000 Packets Of DRDO's Anti-Covid Oral Drug To Be Distributed Today
An anti-coronavirus drug developed by Defence Research and Development Organisation (DRDO) will be launched tomorrow, with Union Defence Minister Rajnath Singh distributing nearly 10,000 doses to some hospitals in the national capital.
-
Regular Ivermectin Use May Cut Risk Of Contracting Covid: Study
Regular use of the oral antiparasitic drug ivermectin may significantly reduce the risk of contracting COVID-19, according to a review of available data by researchers who claim the medicine can help end the pandemic.
-
Pfizer Chief Says Oral Drug For COVID-19 Could Be Ready Next Year: Report
Pfizer CEO Albert Bourla has said that an oral drug for treating coronavirus could be ready next year, adding that the company is working on two antivirals, an oral and an injectable.
-
Glenmark Launches COVID-19 Drug Favipiravir At Rs 103 Per Tablet
As Glenmark Pharmaceuticals launched antiviral drug Favipiravir for the treatment of mild to moderate COVID-19 cases, medical experts on Saturday cautioned against seeing it as a "magic bullet" to treat the deadly virus but said it will be helpful as it can be orally administered and reduce viral load.
-
New Drug 95% Effective Against Sleeping Sickness In Adults: Lancet Study
A new, single-dose oral treatment for sleeping sickness is 95 per cent effective in adults and adolescents, regardless of disease stage, according to a study published in The Lancet Infectious Diseases.
-
Maharashtra Orders Sample Checks On All Syrups After WHO Alert: Report
The drug regulator of Maharashtra has ordered sample checks on all oral liquid solutions in the state, asking for reports on the levels of diethylene glycol and ethylene glycol, CNBC TV18 reported on Thursday.
-
Positive Results In Phase 3 Trial Of Covid Pill, Says Hetero Pharma Group
Drug firm Hetero on Saturday announced positive results of Phase III trials of Movfor (Molnupiravir), an investigational oral antiviral COVID-19 medicine.
-
Pfizer Covid Pill Europe's First Approved Oral Treatment Against Covid
The EU's drug watchdog approved Pfizer's coronavirus pill on Thursday, making it the first oral antiviral treatment for the disease to be authorised in Europe.
-
Game-Changing Made-In-India Anti-Covid Pills Could Be Cleared For Use In Days
Emergency Use Authorisation for the Merck drug Molnupiravir -- an oral antiviral medicine for the treatment of mild-to-moderate COVID-19 -- is likely "within days", Dr Ram Vishwakarma, Chairman of the Covid Strategy Group, CSIR, told NDTV today.
-
Hyderabad Firm Seeks Approval To Produce Generic Merck Covid Pill
The bulk drugs manufacturer Optimus Pharma is seeking domestic regulatory approval to produce a generic version of Merck & Co's oral COVID-19 treatment molnupiravir, the company's top executive told Reuters on Thursday.
-
Shilpa Medicare Gains On Receiving Nod For COVID-19 Adjunct Therapy Drug
2-Deoxy-2-Glucose Oral Powder is approved for the treatment of adjunct therapy in moderate to severe COVID-19 patients, Shilpa Medicare added.
-
Marksans Pharma Shares Gain On USFDA Approval For Pain Killer Drug
Marksans will manufacture the products at its US Food and Drug Administration (USFDA) approved solid oral dosage facility located at Goa.
-
Mankind Pharma Gets DRDO Nod To Manufacture, Sell Covid Drug 2-DG
Drug firm Mankind Pharma today said it has received licence from the Defence Research and Development Organisation (DRDO) to manufacture and market oral 2-deoxy-D-glucose (2-DG), used for the treatment of COVID-19.
-
Oral Drug For Black Fungus Ready for technology transfer: IIT Researchers
Researchers at Indian Institute of Technology, Hyderabad, have developed an oral solution to treat Black Fungus (Mucormycosis) and other fungi and are ready to transfer the technology to take it forward, the premier institute said.
-
First Batch Of Anti-COVID Drug 2-DG Released
The first batch of anti-COVID oral drug 2-DG, developed by the DRDO, was released on Monday by Defence Minister Rajnath Singh and Health Minister Harsh Vardhan.
-
10,000 Packets Of DRDO's Anti-Covid Oral Drug To Be Distributed Today
An anti-coronavirus drug developed by Defence Research and Development Organisation (DRDO) will be launched tomorrow, with Union Defence Minister Rajnath Singh distributing nearly 10,000 doses to some hospitals in the national capital.
-
Regular Ivermectin Use May Cut Risk Of Contracting Covid: Study
Regular use of the oral antiparasitic drug ivermectin may significantly reduce the risk of contracting COVID-19, according to a review of available data by researchers who claim the medicine can help end the pandemic.
-
Pfizer Chief Says Oral Drug For COVID-19 Could Be Ready Next Year: Report
Pfizer CEO Albert Bourla has said that an oral drug for treating coronavirus could be ready next year, adding that the company is working on two antivirals, an oral and an injectable.
-
Glenmark Launches COVID-19 Drug Favipiravir At Rs 103 Per Tablet
As Glenmark Pharmaceuticals launched antiviral drug Favipiravir for the treatment of mild to moderate COVID-19 cases, medical experts on Saturday cautioned against seeing it as a "magic bullet" to treat the deadly virus but said it will be helpful as it can be orally administered and reduce viral load.
